Skip to main content
OTCMKTS:SPHRY

Starpharma News Headlines

$13.45
+0.22 (+1.66 %)
(As of 05/12/2021 11:52 AM ET)
Add
Compare
Today's Range
$13.45
$13.45
50-Day Range
$13.01
$16.53
52-Week Range
$6.20
$19.87
Volume100 shs
Average Volume3,455 shs
Market Capitalization$546.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Starpharma (OTCMKTS SPHRY) News Headlines Today

SourceHeadline
Starpharma (ASX:SPL) share price slides despite COVID spray rugby dealStarpharma (ASX:SPL) share price slides despite COVID spray rugby deal
msn.com - May 11 at 7:05 AM
Starpharma (ASX:SPL) share price surges higher on COVID product updateStarpharma (ASX:SPL) share price surges higher on COVID product update
msn.com - May 5 at 10:20 PM
Starpharma Holdings Limited (OTCMKTS:SPHRY) Sees Significant Decrease in Short InterestStarpharma Holdings Limited (OTCMKTS:SPHRY) Sees Significant Decrease in Short Interest
americanbankingnews.com - April 28 at 3:06 PM
Starpharma (ASX:SPL) share price edges higher on updateStarpharma (ASX:SPL) share price edges higher on update
msn.com - April 26 at 11:27 PM
Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest UpdateStarpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Update
americanbankingnews.com - April 18 at 1:06 PM
Why the Starpharma (ASX:SPL) share price is up 27% in 2021Why the Starpharma (ASX:SPL) share price is up 27% in 2021
msn.com - April 13 at 12:38 AM
Starpharma (ASX:SPL) share price pushes higher on COVID-19 nasal spray updateStarpharma (ASX:SPL) share price pushes higher on COVID-19 nasal spray update
msn.com - March 25 at 12:09 AM
Starpharma Up With News, Down With None; Timing Entry Makes SenseStarpharma Up With News, Down With None; Timing Entry Makes Sense
seekingalpha.com - February 27 at 7:10 AM
Here’s why the Starpharma (ASX:SPL) share price just stormed to a record highHere’s why the Starpharma (ASX:SPL) share price just stormed to a record high
msn.com - February 11 at 7:31 PM
Why the Starpharma (ASX:SPL) share price hit a record high todayWhy the Starpharma (ASX:SPL) share price hit a record high today
msn.com - February 8 at 8:01 PM
Starpharma (ASX:SPL) share price dips despite positive updateStarpharma (ASX:SPL) share price dips despite positive update
msn.com - December 21 at 11:41 PM
Our Take On Starpharma Holdings (ASX:SPL) CEO SalaryOur Take On Starpharma Holdings' (ASX:SPL) CEO Salary
finance.yahoo.com - December 3 at 9:39 PM
Why the Starpharma (ASX:SPL) share price is racing higher todayWhy the Starpharma (ASX:SPL) share price is racing higher today
fool.com.au - November 19 at 3:25 AM
Will COVID Disappear Soon Or Do Investors Need To Pay Attention?Will COVID Disappear Soon Or Do Investors Need To Pay Attention?
seekingalpha.com - November 4 at 6:36 PM
Starpharma raises $48.9 million to accelerate development of dendrimer productStarpharma raises $48.9 million to accelerate development of dendrimer product
proactiveinvestors.com.hk - October 30 at 7:57 AM
Starpharma Holdings Limiteds (ASX:SPL) Path To ProfitabilityStarpharma Holdings Limited's (ASX:SPL) Path To Profitability
finance.yahoo.com - October 29 at 2:52 AM
Are Investors Undervaluing Starpharma Holdings Limited (ASX:SPL) By 39%?Are Investors Undervaluing Starpharma Holdings Limited (ASX:SPL) By 39%?
finance.yahoo.com - September 23 at 1:37 AM
Starpharma’s COVID-19 nasal spray shows positive effect against COVID-19Starpharma’s COVID-19 nasal spray shows positive effect against COVID-19
seekingalpha.com - September 14 at 5:52 PM
The Starpharma share price jumps on new partnership dealThe Starpharma share price jumps on new partnership deal
msn.com - August 17 at 8:16 AM
A Neglected Treatment Space For COVID-19A Neglected Treatment Space For COVID-19
seekingalpha.com - August 6 at 8:13 AM
What Type Of Shareholders Own The Most Number of Starpharma Holdings Limited (ASX:SPL) Shares?What Type Of Shareholders Own The Most Number of Starpharma Holdings Limited (ASX:SPL) Shares?
finance.yahoo.com - July 28 at 1:10 AM
Is Starpharma Holdings Limited's (ASX:SPL) CEO Overpaid Relative To Its Peers?Is Starpharma Holdings Limited's (ASX:SPL) CEO Overpaid Relative To Its Peers?
finance.yahoo.com - May 5 at 3:52 AM
Starpharmas SPL7013 Antiviral Takes On COVID-19Starpharma's SPL7013 Antiviral Takes On COVID-19
seekingalpha.com - May 4 at 5:48 PM
Starpharma to develop COVID-19 treatmentStarpharma to develop COVID-19 treatment
seekingalpha.com - April 16 at 10:02 AM
Why a2 Milk, Fisher & Paykel Healthcare, Star, & Starpharma are pushing higherWhy a2 Milk, Fisher & Paykel Healthcare, Star, & Starpharma are pushing higher
www.fool.com.au - April 15 at 11:11 PM
Drug Delivery Technology Market to Hold a High Potential for Growth by 2026 | Future Market InsightsDrug Delivery Technology Market to Hold a High Potential for Growth by 2026 | Future Market Insights
www.marketwatch.com - March 23 at 12:22 PM
Starpharma share price tumbles 6% lower on half year updateStarpharma share price tumbles 6% lower on half year update
www.fool.com.au - February 23 at 11:39 PM
Starpharma share price charges higher on product launch newsStarpharma share price charges higher on product launch news
www.fool.com.au - February 13 at 12:39 AM
Starpharma share price higher on clinical trial updateStarpharma share price higher on clinical trial update
www.fool.com.au - February 10 at 10:10 PM
Starpharma Holdings Limited's (ASX:SPL) Path To ProfitabilityStarpharma Holdings Limited's (ASX:SPL) Path To Profitability
finance.yahoo.com - January 30 at 10:28 PM
Starpharma: Commencement of Phase 1 Trial for AZD0466 Utilising DEP ® Delivery TechnologyStarpharma: Commencement of Phase 1 Trial for AZD0466 Utilising DEP ® Delivery Technology
www.businesswire.com - December 31 at 2:24 AM
Healthcare Nanotechnology (Nanomedicine) Market 2019 Size, Status and Technology Growth 2019-2024Healthcare Nanotechnology (Nanomedicine) Market 2019 Size, Status and Technology Growth 2019-2024
www.marketwatch.com - December 17 at 7:58 AM
We're Not Worried About Starpharma Holdings's (ASX:SPL) Cash BurnWe're Not Worried About Starpharma Holdings's (ASX:SPL) Cash Burn
finance.yahoo.com - December 16 at 10:34 PM
Starpharma share price on watch after European approval newsStarpharma share price on watch after European approval news
www.msn.com - November 20 at 11:44 PM
Starpharma share price charges higher on UK VivaGel BV launchStarpharma share price charges higher on UK VivaGel BV launch
www.fool.com.au - November 12 at 7:53 PM
Should You Worry About Starpharma Holdings Limited's (ASX:SPL) CEO Salary Level?Should You Worry About Starpharma Holdings Limited's (ASX:SPL) CEO Salary Level?
finance.yahoo.com - October 17 at 10:24 PM
FDA Clearance For Astra Zeneca/Starpharma Potential Blockbuster Cancer DrugFDA Clearance For Astra Zeneca/Starpharma Potential Blockbuster Cancer Drug
seekingalpha.com - October 1 at 2:25 PM
Why Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lowerWhy Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lower
www.fool.com.au - September 27 at 2:08 AM
Why the Stavely Minerals share price rocketed 287% higher todayWhy the Stavely Minerals share price rocketed 287% higher today
au.finance.yahoo.com - September 26 at 4:34 AM
Why BINGO, FlexiGroup, Monadelphous, & Starpharma shares stormed higherWhy BINGO, FlexiGroup, Monadelphous, & Starpharma shares stormed higher
www.fool.com.au - September 26 at 4:34 AM
The Starpharma Holdings (ASX:SPL) Share Price Has Gained 62% And Shareholders Are Hoping For MoreThe Starpharma Holdings (ASX:SPL) Share Price Has Gained 62% And Shareholders Are Hoping For More
finance.yahoo.com - September 6 at 9:24 AM
Why the PolyNovo share price surged higher on ThursdayWhy the PolyNovo share price surged higher on Thursday
www.fool.com.au - August 8 at 11:28 AM
Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?
finance.yahoo.com - July 31 at 11:16 PM
This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.